Hans Pruijt

490 total citations
15 papers, 128 citations indexed

About

Hans Pruijt is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans Pruijt has authored 15 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans Pruijt's work include Colorectal Cancer Treatments and Studies (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Colorectal and Anal Carcinomas (3 papers). Hans Pruijt is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Colorectal and Anal Carcinomas (3 papers). Hans Pruijt collaborates with scholars based in Netherlands, Denmark and Belgium. Hans Pruijt's co-authors include Koop Bosscha, V.E.P.P. Lemmens, Felice N. van Erning, Hein Putter, Daniel J. Lips, Vincent T.H.B.M. Smit, Gerrit‐Jan Liefers, Rob H.A. Verhoeven, Hanneke W.M. van Laarhoven and Margreet van Putten and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Hans Pruijt

13 papers receiving 127 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Pruijt Netherlands 6 72 47 42 32 22 15 128
Jennifer Borowsky Australia 8 108 1.5× 41 0.9× 69 1.6× 27 0.8× 12 0.5× 10 174
Keitaro Shimozaki Japan 10 191 2.7× 115 2.4× 39 0.9× 56 1.8× 22 1.0× 33 257
Rocco Giannicola Italy 8 99 1.4× 62 1.3× 15 0.4× 22 0.7× 29 1.3× 16 196
Enxiao Li China 6 106 1.5× 55 1.2× 14 0.3× 49 1.5× 9 0.4× 11 160
Minori Koshiji Rosales United States 6 135 1.9× 75 1.6× 21 0.5× 31 1.0× 29 1.3× 11 158
Qingxia Fan China 7 112 1.6× 49 1.0× 28 0.7× 37 1.2× 25 1.1× 17 156
Akesu Sujie China 8 114 1.6× 90 1.9× 9 0.2× 79 2.5× 22 1.0× 17 180
Pierre-Emmanuel Brachet France 6 47 0.7× 39 0.8× 10 0.2× 32 1.0× 5 0.2× 18 118
Coralie Cantarel France 6 187 2.6× 61 1.3× 65 1.5× 66 2.1× 31 1.4× 17 220
Daniel López‐Trabada France 5 114 1.6× 29 0.6× 103 2.5× 22 0.7× 10 0.5× 10 174

Countries citing papers authored by Hans Pruijt

Since Specialization
Citations

This map shows the geographic impact of Hans Pruijt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Pruijt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Pruijt more than expected).

Fields of papers citing papers by Hans Pruijt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Pruijt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Pruijt. The network helps show where Hans Pruijt may publish in the future.

Co-authorship network of co-authors of Hans Pruijt

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Pruijt. A scholar is included among the top collaborators of Hans Pruijt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Pruijt. Hans Pruijt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hooff, Sander R. van, Anita E. Grootemaat, Monique A.J. van Eijndhoven, et al.. (2025). Mesenchymal Colorectal Cancers Secrete Vesicles With Unique Cargo That Can Be Used for Liquid Biopsy Based Diagnostics. Journal of Extracellular Vesicles. 14(11). e70171–e70171.
2.
Wang, Steven, Marcel Nijland, Rinske Boersma, et al.. (2025). Prospective validation of end of treatment ctDNA-MRD by PhasED-Seq in DLBCL patients from a national trial.. Journal of Clinical Oncology. 43(16_suppl). 7000–7000.
3.
Buffart, Tineke E., Riet Hilhorst, Hans Pruijt, et al.. (2021). Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients. Clinical Proteomics. 18(1). 8–8. 3 indexed citations
4.
Putten, Margreet van, V.E.P.P. Lemmens, Hanneke W.M. van Laarhoven, et al.. (2019). Poor compliance with perioperative chemotherapy for resectable gastric cancer and its impact on survival. European Journal of Surgical Oncology. 45(10). 1926–1933. 17 indexed citations
5.
Lugtenburg, Elly, Peter de Nully Brown, Bronno van der Holt, et al.. (2019). Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Results from a randomized HOVON-Nordic Lymphoma Group phase III study.. Journal of Clinical Oncology. 37(15_suppl). 7507–7507. 5 indexed citations
6.
Lugtenburg, Pieternella J., Peter de Nully Brown, Bronno van der Holt, et al.. (2019). RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY. Hematological Oncology. 37(S2). 79–80. 1 indexed citations
7.
Bassett, Paul, Hans Pruijt, Arnoud J.G. Knoops, et al.. (2018). Mild Hypogammaglobulinemia Can Be a Serious Condition. Frontiers in Immunology. 9. 2384–2384. 17 indexed citations
8.
Kwakman, R., Arnold Baars, Henk Boot, et al.. (2017). Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in Western cancer patients. European Journal of Cancer. 72. S69–S69. 1 indexed citations
9.
Erning, Felice N. van, Hans Pruijt, Albert J. ten Tije, et al.. (2016). The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancer. Journal of Geriatric Oncology. 8(1). 37–43. 5 indexed citations
10.
11.
Vogelaar, F. Jeroen, Felice N. van Erning, Marlies S. Reimers, et al.. (2015). The Prognostic Value of Microsatellite Instability, KRAS, BRAF and PIK3CA Mutations in Stage II Colon Cancer Patients. Molecular Medicine. 21(1). 1038–1046. 17 indexed citations
12.
Erning, Felice N. van, Maryska L.G. Janssen‐Heijnen, Geert‐Jan Creemers, et al.. (2015). Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: A qualitative insight into the perspectives of surgeons and medical oncologists. Journal of Geriatric Oncology. 6(3). 219–224. 8 indexed citations
13.
Bernards, Nienke, Geert-Jan Creemers, Grard A. P. Nieuwenhuijzen, et al.. (2013). No Improvement in Median Survival for Patients with Metastasized Gastric Cancer Despite Increased Use of Chemotherapy. Annals of Oncology. 24. iv42–iv42. 1 indexed citations
14.
Lips, Daniel J., Gerrit‐Jan Liefers, Vincent T.H.B.M. Smit, et al.. (2011). The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study. BMC Surgery. 11(1). 11–11. 36 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Borowsky Breakdown of academic impact, for papers by Keitaro Shimozaki Breakdown of academic impact, for papers by Rocco Giannicola Breakdown of academic impact, for papers by Enxiao Li Breakdown of academic impact, for papers by Minori Koshiji Rosales Breakdown of academic impact, for papers by Qingxia Fan Breakdown of academic impact, for papers by Akesu Sujie Breakdown of academic impact, for papers by Pierre-Emmanuel Brachet Breakdown of academic impact, for papers by Coralie Cantarel Breakdown of academic impact, for papers by Daniel López‐Trabada
Rankless by CCL
2026